Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

npj Vaccines
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. npj vaccines
  3. articles
  4. article
USTAT: Unified Sequential Template Amplification and Transcription—a fully synthetic mRNA manufacturing platform
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 09 April 2026

USTAT: Unified Sequential Template Amplification and Transcription—a fully synthetic mRNA manufacturing platform

  • Swap Ghosh1,
  • Carrie L. Simms1,
  • Sage D. Rohrer1,2,
  • Carlos H. Castaneda2,
  • Joseph W. Saelens3,
  • Kaley Niehaus1,
  • Michael J. Swyers1 &
  • …
  • Joseph Russo1 

npj Vaccines , Article number:  (2026) Cite this article

  • 533 Accesses

  • 1 Altmetric

  • Metrics details

We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.

Subjects

  • Biological techniques
  • Biotechnology
  • Microbiology
  • Molecular biology

Abstract

mRNA vaccines have emerged as a transformative modality for infectious disease prevention. In response to the emergence of SARS-CoV-2, large-scale in vitro transcription (IVT) of mRNA vaccines was developed. Large-scale IVT currently relies on linearized plasmid DNA (pDNA) as a template for mRNA production. Linearized pDNA production presents several challenges at manufacturing scale, including removal of residual host-cell DNA, protein, endotoxins, and antibiotics. Additionally, pDNA-derived sequences irrelevant to mRNA production must be removed from the final product. Finally, the generation of linear pDNA template is laborious, which reduces mRNA production speed, a renowned advantage of this technology. Enzymatic DNA amplification strategies such as rolling circle amplification (RCA) of a synthetic circular DNA molecule offer a rapid, isothermal reaction as an alternative to pDNA. Therefore, we have developed a fully synthetic, single-vessel mRNA manufacturing platform. Beginning with a chemically synthesized circular DNA template, we amplify via a fit-for-purpose RCA, linearize with a TypeIIS restriction enzyme (RE), and perform IVT in a single vessel. The entire process—from circular template to mRNA—can be completed in as little as two days. This method, termed Unified Sequential Template Amplification and Transcription (USTAT), eliminates bacterial components, large volume pDNA production, and enables rapid, modular mRNA production.

Similar content being viewed by others

COMPARING vaccine manufacturing technologies recombinant DNA vs in vitro transcribed (IVT) mRNA

Article Open access 18 September 2024

Systematic analysis of COVID-19 mRNA vaccines using four orthogonal approaches demonstrates no excessive DNA impurities

Article Open access 13 December 2025

The design, manufacture and LNP formulation of mRNA for research use

Article 10 June 2025

Data availability

The data supporting the findings are contained within the manuscript or supplementary files. Genetic data is present in the supplementary data file. Additional raw data are available from the corresponding author upon request.

References

  1. Xenopoulos, A. & Pattnaik, P. Production and purification of plasmid DNA vaccines: Is there scope for further innovation?. Expert Rev. Vaccines 13, 1537–1551 (2014).

    Google Scholar 

  2. Piao, X. et al. Supercoiled DNA percentage: a key in-process control of linear DNA template for mRNA drug substance manufacturing. Mol. Ther. Nucleic Acids 35, 102223 (2024).

    Google Scholar 

  3. Dean, F. B., Nelson, J. R., Giesler, T. L. & Lasken, R. S. Rapid amplification of plasmid and phage DNA using Phi29 DNA polymerase and multiply-primed rolling circle amplification. Genome Res. 11, 1095–1099 (2001).

    Google Scholar 

  4. Fidelity of phi 29 DNA polymerase. Comparison between protein-primed initiation and DNA polymerization. J. Biol. Chem. 268, 2719–2726 (1993).

    Google Scholar 

  5. Garmendia, C., Bernad, A., Esteban, J. A., Blanco, L. & Salas, M. The bacteriophage phi 29 DNA polymerase, a proofreading enzyme. J. Biol. Chem. 267, 2594–2599 (1992).

    Google Scholar 

  6. Kumar, G. & Chernaya, G. Cell-free protein synthesis using multiply-primed rolling circle amplification products. BioTechniques 47, 637–639 (2009).

    Google Scholar 

  7. van Emmerik, C. L. et al. Ramified rolling circle amplification for synthesis of nucleosomal DNA sequences. Anal. Biochem. 588, 113469 (2020).

    Google Scholar 

  8. Engler, C., Gruetzner, R., Kandzia, R. & Marillonnet, S. Golden gate shuffling: a one-pot DNA shuffling method based on type IIs restriction enzymes. PLoS One 4, e5553 (2009).

    Google Scholar 

  9. Bauer, R. J. et al. Comparative analysis of the end-joining activity of several DNA ligases. PLoS One 12, e0190062 (2017).

    Google Scholar 

  10. Strzelecki, P. et al. Enhanced Golden Gate Assembly: evaluating overhang strength for improved ligation efficiency. Nucleic Acids Res. 52, e95 (2024).

    Google Scholar 

  11. Shi, K. et al. T4 DNA ligase structure reveals a prototypical ATP-dependent ligase with a unique mode of sliding clamp interaction. Nucleic Acids Res. 46, 10474–10488 (2018).

    Google Scholar 

  12. Inoue, H., Nojima, H. & Okayama, H. High efficiency transformation of E. coli with plasmids. Gene 96, 23–28 (1990).

  13. Miyoshi, D., Karimata, H. & Sugimoto, N. The effect of 1,2-propanediol on DNA structure and stability. Nucleic Acids Symposium Series 203–204 (Oxford University Press, 2006).

  14. Ali, M. M. et al. Rolling circle amplification: a versatile tool for chemical biology, materials science and medicine. Chem. Soc. Rev. 43, 3324–3341 (2014).

    Google Scholar 

  15. Lizardi, P. M. et al. Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat. Genet. 19, 225–232 (1998).

    Google Scholar 

  16. Baner, J., Nilsson, M., Mendel-Hartvig, M. & Landegren, U. Signal amplification of padlock probes by rolling circle replication. Nucleic Acids Res. 26, 5073–5078 (1998).

    Google Scholar 

  17. Garafutdinov, R. R., Sakhabutdinova, A. R., Gilvanov, A. R. & Chemeris, A. V. Rolling circle amplification as a universal method for the analysis of a wide range of biological targets. Russian J. Bioorg. Chem. 47, 1172–1189 (2021).

    Google Scholar 

  18. Lenk, R. et al. Understanding the impact of in vitro transcription byproducts and contaminants. Front. Mol. Biosc. 11, 1426129 (2024).

  19. Levy, M. S. et al. Effect of shear on plasmid DNA in solution. Bioprocess Eng. 20, 7–13 (1999).

  20. Levy, M. S., O’Kennedy, R. D., Ayazi-Shamlou, P. & Dunnill, P. Biochemical engineering approaches to the challenges of producing pure plasmid DNA. Trends Biotechnol. 18, 296–305 (2000).

  21. Nair, V. K., Sharma, C. & Ghosh, S. Mitigating the non-specific rolling circle amplification: a comprehensive assessment of the role of ligation and digestion methods. ChemRxiv https://doi.org/10.26434/chemrxiv-2022-mxtb3-v3 (2022).

  22. Inoue, J., Shigemori, Y. & Mikawa, T. Improvements of rolling circle amplification (RCA) efficiency and accuracy using Thermus thermophilus SSB mutant protein. Nucleic Acids Res. 34, e69 (2006).

    Google Scholar 

  23. Baker, Y. R. et al. Expanding the chemical functionality of DNA nanomaterials generated by rolling circle amplification. Nucleic Acids Res. 49, 9042–9052 (2021).

  24. Kieser, R. E. & Budowle, B. Rolling circle amplification: a (random) primer on the enrichment of an infinite linear DNA template. WIREs Forensic Sci. 2, e1359 (2020).

  25. Skerra, A. Phosphorothioate primers improve the amplification of DNA sequences by DNA polymerases with proofreading activity. Nucleic Acids Res. 20, 3551–3554 (1992).

  26. Martín, D. S. et al. Reduced amplification by phi29 DNA polymerase in the presence of unbound oligos during reaction in RCA. Biosens. Bioelectron. X 17, 100456 (2024).

    Google Scholar 

  27. Lagunavicius, A., Kiveryte, Z., Zimbaite-Ruskuliene, V., Radzvilavicius, T. & Janulaitis, A. Duality of polynucleotide substrates for Phi29 DNA polymerase: 3′→5′ RNase activity of the enzyme. RNA 14, 503–513 (2008).

    Google Scholar 

  28. Blanco, L. & Salas, M. Characterization and purification of a proofreading DNA polymerase from bacteriophage ϕ29. J. Biol. Chem. 259, XX (1984).

  29. Krzywkowski, T., Kühnemund, M., Wu, D. & Nilsson, M. Limited reverse transcriptase activity of phi29 DNA polymerase. Nucleic Acids Res. 46, 3625–3632 (2018).

    Google Scholar 

  30. Gao, Y., Wolf, L. K. & Georgiadis, R. M. Secondary structure effects on DNA hybridization kinetics: a solution versus surface comparison. Nucleic Acids Res. 34, 3370–3377 (2006).

  31. Klenow, H. & Henningsen, I. Effect of monovalent cations on the activity of the DNA polymerase of Escherichia coli B. Eur. J. Biochem. 9, 133–141 (1969).

    Google Scholar 

  32. Gohara, D. W. & Di Cera, E. Molecular mechanisms of enzyme activation by monovalent cations. J. Biol. Chem. 291, 20840–20848 (2016).

    Google Scholar 

  33. Sun, Y. et al. Unraveling the salt tolerance of Phi29 DNA polymerase using compartmentalized self-replication and microfluidics platform. Front. Microbiol. 14, 1267196 (2023).

  34. Maity, A., Singh, A. & Singh, N. Differential stability of DNA based on salt concentration. Eur. Biophys. J. 46, 33–40 (2017).

    Google Scholar 

  35. Wolffs, P., Grage, H., Hagberg, O. & Rådström, P. Impact of DNA polymerases and their buffer systems on quantitative real-time PCR. J. Clin. Microbiol. 42, 408–411 (2004).

    Google Scholar 

  36. Nishimoto, N., Suzuki, M. & Izuta, S. Effect of pH on the misincorporation rate of DNA polymerase η. Biol. Pharm. Bull. 39, 953–958 (2016).

    Google Scholar 

  37. KA, E. & TA, K. DNA polymerase fidelity and the polymerase chain reaction. PCR Methods Appl. 1, 17–24 (1991).

  38. Stephen, C. & Mishanina, T. V. Alkaline pH has an unexpected effect on transcriptional pausing during synthesis of the Escherichia coli pH-responsive riboswitch. J. Biol. Chem. 298, 102302 (2022).

  39. Özay, B. & McCalla, S. E. A review of reaction enhancement strategies for isothermal nucleic acid amplification reactions. Sens. Actuators Rep. 3, 100033 (2021).

    Google Scholar 

  40. Mok, E., Wee, E., Wang, Y. & Trau, M. Comprehensive evaluation of molecular enhancers of the isothermal exponential amplification reaction. Sci. Rep. 6, 37837 (2016).

    Google Scholar 

  41. Karunanathie, H., Kee, P. S., Ng, S. F., Kennedy, M. A. & Chua, E. W. PCR enhancers: types, mechanisms, and applications in long-range PCR. Biochimie 197, 130–143 (2022).

    Google Scholar 

  42. Chevet, E., Lemaître, G. & Katinka, M. D. Low concentrations of tetramethylammonium chloride increase yield and specificity of PCR. Nucleic Acids Res. 23, 3343–3344 (1995).

    Google Scholar 

  43. Wang, J. et al. Exponential amplification of DNA with very low background using graphene oxide and single-stranded binding protein to suppress non-specific amplification. Microchim. Acta 182, 1095–1101 (2015).

    Google Scholar 

  44. Wartell, R. M. & Benight, A. S. Thermal denaturation of DNA molecules: a comparison of theory with experiment. Phys. Rep. 126, 67–107 (1985).

  45. von Hippel, P. H. & Berg, O. G. On the specificity of DNA-protein interactions. Proc. Natl. Acad. Sci. USA 83, 1608–1612 (1986).

  46. Chen, Y. G. & Hur, S. Cellular origins of dsRNA, their recognition and consequences. Nat. Rev. Mol. Cell Biol. 23, 286–301 (2021).

  47. Baiersdörfer, M. A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA. Mol. Ther. Nucleic Acids 15, 26–35 (2019).

  48. Sharabrin, S. V. et al. Removal of double-stranded RNA contaminants during template-directed synthesis of mRNA. Bull. Exp. Biol. Med. 176, 751–755 (2024).

  49. Popova, P. G. et al. Effect of in vitro transcription conditions on yield of high quality messenger and self-amplifying RNA. Eur. J. Pharm. Biopharm. 198, 114247 (2024).

    Google Scholar 

Download references

Acknowledgements

We thank Erik Barton and members of Pfizer Bioprocess R&D for their thoughtful input and review of the manuscript. No funding was received for this research. The authors declare no competing financial or non-financial interests.

Author information

Authors and Affiliations

  1. Molecular and Cellular Technologies, Bioprocess R&D, Biotherapeutics Pharmaceutical Sciences, Preclinical & Translational Sciences, Pfizer Inc., Chesterfield, MO, USA

    Swap Ghosh, Carrie L. Simms, Sage D. Rohrer, Kaley Niehaus, Michael J. Swyers & Joseph Russo

  2. Analytical R&D, Biotherapeutics Pharmaceutical Sciences, Preclinical & Translational Sciences, Pfizer Inc., Chesterfield, MO, USA

    Sage D. Rohrer & Carlos H. Castaneda

  3. Machine Learning and Computational Sciences, Preclinical & Translational Sciences, Pfizer Inc., Cambridge, MA, USA

    Joseph W. Saelens

Authors
  1. Swap Ghosh
    View author publications

    Search author on:PubMed Google Scholar

  2. Carrie L. Simms
    View author publications

    Search author on:PubMed Google Scholar

  3. Sage D. Rohrer
    View author publications

    Search author on:PubMed Google Scholar

  4. Carlos H. Castaneda
    View author publications

    Search author on:PubMed Google Scholar

  5. Joseph W. Saelens
    View author publications

    Search author on:PubMed Google Scholar

  6. Kaley Niehaus
    View author publications

    Search author on:PubMed Google Scholar

  7. Michael J. Swyers
    View author publications

    Search author on:PubMed Google Scholar

  8. Joseph Russo
    View author publications

    Search author on:PubMed Google Scholar

Contributions

S.G, C.L.S., S.D.R., C.H.C., J.W.S., K.N., M.J.S., and J.R. conceptualized ideas and experiments presented in this work. S.G, C.L.S., S.D.R., C.H.C., J.W.S., K.N., M.J.S., and J.R. performed experiments presented or related to this work to develop conclusions. S.G, C.L.S., S.D.R., C.H.C., J.W.S., K.N., M.J.S., and J.R. wrote the main manuscript. S.G, C.L.S., S.D.R., C.H.C., J.W.S., K.N., M.J.S., and J.R. prepared figures. S.G, C.L.S., S.D.R., C.H.C., J.W.S., K.N., M.J.S., and J.R. reviewed the manuscript.

Corresponding author

Correspondence to Joseph Russo.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghosh, S., Simms, C.L., Rohrer, S.D. et al. USTAT: Unified Sequential Template Amplification and Transcription—a fully synthetic mRNA manufacturing platform. npj Vaccines (2026). https://doi.org/10.1038/s41541-026-01434-8

Download citation

  • Received: 02 September 2025

  • Accepted: 17 March 2026

  • Published: 09 April 2026

  • DOI: https://doi.org/10.1038/s41541-026-01434-8

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Collections
  • Follow us on X
  • Sign up for alerts
  • RSS feed

About the journal

  • Aims & Scope
  • Content types
  • Journal Information
  • About the Editors
  • Contact
  • Open Access
  • Calls for Papers
  • Editorial policies
  • Article Processing Charges
  • Journal Metrics
  • About the Partner

Publish with us

  • For Authors and Referees
  • Language editing services
  • Open access funding
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

npj Vaccines (npj Vaccines)

ISSN 2059-0105 (online)

nature.com footer links

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2026 Springer Nature Limited

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research